(Q51668925)

9 April 2018

title

Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay. (English)

1 reference

9 April 2018

1 reference

1 reference

8

1 reference

9 April 2018

Ingrid E Lundberg

9

1 reference

9 April 2018

Andrea Doria

10

object named as

Andrea Doria

1 reference

9 April 2018

7

Margherita Zen

1 reference

9 April 2018

author name string

Anna Ghirardello

1

1 reference

9 April 2018

Mariaelisa Rampudda

2

1 reference

9 April 2018

Louise Ekholm

3

1 reference

9 April 2018

Nicola Bassi

4

1 reference

9 April 2018

Elena Tarricone

5

1 reference

9 April 2018

Sandra Zampieri

6

1 reference

9 April 2018

publication date

19 August 2010

1 reference

9 April 2018

published in

Rheumatology

1 reference

9 April 2018

volume

49

1 reference

9 April 2018

page(s)

2370-2374

1 reference

9 April 2018

issue

12

1 reference

9 April 2018

Autoantibody profiles in the sera of European patients with myositis

cites work

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ281

Clinical implications of autoantibody screening in patients with autoimmune myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ281

The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ281

Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ281

Contribution of autoantibodies to the diagnosis and nosology of inflammatory muscle disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ281

Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ281

Commercial blot assays in the diagnosis of systemic rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ281

Polymyositis and dermatomyositis (first of two parts)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ281

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ281

Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with IgG anticardiolipin antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ281

Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ281

Infections, rheumatism and autoimmunity: the conflicting relationship between humans and their environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ281

Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ281

Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ281

Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ281

10.1093/RHEUMATOLOGY/KEQ281

21 January 2018

Identifiers

DOI

1 reference

9 April 2018

PubMed ID

20724434

1 reference

9 April 2018